ImmunoMet

Website

Developer of novel anti-tumor and immuno-oncology therapies designed to treat cancer patients. The company's therapies include drugs and metabolic regulators to increase patient survival by disrupting...

Healthcare
Houston, TX, United States
Founded 2015
8 employees
Website
Valuation
$46M
Market implied
Share Price
N/A
Total Raised
$42.9M
Last Round
N/A
Investors
+9 other investors
View all 9 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock ImmunoMet's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required